This bulletin focusses on type 2 diabetes and covers the following topics:
- Hypoglycaemic agents in patients with type 2 diabetes
- Long-acting insulin analogues in patients with type 2 diabetes
- Self-monitoring of blood glucose in patients with type 2 diabetes
For each of these therapeutic topic areas within type 2 diabetes the evidence base is summarised and current prescribing data are reviewed.
Action: Clinicians who prescribe for patients with type 2 diabetes and who are striving to deliver value for money while maintaining or improving the quality of care will find this information is useful and informative.
|« New contraindications for strontium ranelate||Script charge increase for 2012 »|